Figure 1
From: High-risk HPV type-specific clearance rates in cervical screening
Management of women in the POBASCAM study who were advised to return for repeat testing at 6 and 18 months.
Figure 1 | British Journal of Cancer
From: High-risk HPV type-specific clearance rates in cervical screening
Management of women in the POBASCAM study who were advised to return for repeat testing at 6 and 18 months.
